Is NCT03362411 results overdue?

Yes — results are overdue. Primary completion was 2018-02-01; the FDAAA-801 reporting deadline (2019-02-01) passed 2743 days ago and no results are posted on ClinicalTrials.gov.

A Study to Assess the Absorption of a Single Dose of BMS-986205 in Healthy Volunteers When Administered as a Crushed Tablet Orally or Crushed Tablet Suspension Via Nasogastric Tube, as Compared to a Tablet

NCT ID	NCT03362411 ↗
Sponsor	Bristol-Myers Squibb (INDUSTRY)
Public issuer	BRISTOL MYERS SQUIBB CO — BMY (CIK 0000014272) best-effort name match, 95% conf — verify on EDGAR ↗
Phase	PHASE1
Status	COMPLETED
Primary completion	2018-02-01 (ACTUAL)
Reporting deadline	2019-02-01 (completion + 365d)
Days overdue	2743
Results posted	No — check results tab ↗
FDA-regulated	drug: yes, device: no
Provenance	Flagged overdue on 2026-06-21 · SHA-256 `c8ec3029c0affc6b…` (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03362411. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.